GMVAX Mutual Fund

NAV$19.01

Fund Essentials - as of Feb 28, 2026

Net Assets
$3M
Expense Ratio
1.17%
Dividend Yield (Current)
4.79%
Holdings
99
Inception Date
Jan 31, 2014
Fund Family
Goldman Sachs Asset Management
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+20.34%
1 Year+30.26%
3 Year+14.55%
5 Year+7.81%
10 Year+10.09%

Asset Allocation

Stocks: 98.90%
Cash: 1.10%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
COHRCoherent, Inc2.63%
MTSIMacom Technology Solutions Holdings, Inc.2.63%
MTZMastec Inc2.05%
NVT:LNNvent Electric Pl1.95%
ATIAti Inc1.86%
Top 10 Concentration: 19.04%Report Date: Feb 28, 2026
Download all 99 holdings for GMVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
4.79%
Frequency
Annually
Latest Distribution
$0.04
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how GMVAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

GMVAX Mutual Fund Overview

GMVAX Mutual Fund (Goldman Sachs Small/Mid Cap Value Fund Class A) is managed by Goldman Sachs Asset Management with $2.6M in net assets. GMVAX expense ratio is 1.17%, holding 99 positions across sectors including Industrials, Information Technology, Financials. Inception date: 2014-01-31.

GMVAX performance shows a YTD return of 20.34%. The 1-year return is 30.26% and the 5-year return is 7.81%. GMVAX dividend yield stands at 4.79%, paid annually.

GMVAX top holdings include Coherent, Inc (2.6%), Macom Technology Solutions Holdings, Inc. (2.6%), Mastec Inc (2.0%), Nvent Electric Pl (1.9%), Ati Inc (1.9%). View all GMVAX holdings, sector breakdown, or dividend history.

GMVAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GMVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.